The histaminergic H1, H2, and H3 receptors of the lateral septum differentially mediate the anxiolytic-like effects of histamine on rats' defensive behaviors in the elevated plus maze and novelty-induced suppression of feeding paradigm

Physiology and Behavior

Volumn 116-117, Issue , 2013, Pages 66-74

  Chee, San San A ^a   Menard, Janet L ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Ciproxifan; Defensive behavior; Histamine; Lateral septum; Pyrilamine; Ranitidine

Indexed keywords

HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; MEPYRAMINE; RANITIDINE; ANXIOLYTIC AGENT; HISTAMINE RECEPTOR; HISTAMINERGIC RECEPTOR AFFECTING AGENT;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DISSOCIATION; ELEVATED PLUS MAZE; FEEDING BEHAVIOR; FOLLOW UP; MALE; MAZE TEST; NONHUMAN; NOVELTY INDUCED SUPPRESSION OF FEEDING PARADIGM; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; TRANQUILIZING ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL; CONTROLLED CLINICAL TRIAL; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXPLORATORY BEHAVIOR; LONG EVANS RAT; METABOLISM; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SEPTUM PELLUCIDUM; DRUG EFFECTS; DRUG THERAPY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; HISTAMINE AGENTS; MALE; MAZE LEARNING; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTORS, HISTAMINE; SEPTUM OF BRAIN;

EID: 84877036153     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.03.016     Document Type: Article

References (78)

1. Haas H., Panula P. The role of histamine and the tuberomammillary nucleus in the nervous system. Nat Rev Neurosci 2003, 4:121-130.
2. Ito C. The role of brain histamine in acute and chronic stresses. Biomed Pharmacother 2000, 54:263-267.
3. Panula P., Yang H.Y., Costca E. Histamine-containing neurons in the rat hypothalamus. Proc Nat Acad Sci U S A 1984, 81:2572-2576.
4. Watanabe T., Taguchi Y., Shiosakua S., Tanaka J., Kubota H., Terano Y., et al. Distribution of the histaminergic neuron system in the central nervous system of rats; a fluorescent immunohistochemical analysis with histidine decarboxylase as a marker. Brain Res 1984, 295:13-25.
5. Brown E., Stevens D., Haasv H. The physiology of brain histamine. Prog Neurobiol 2001, 63:637-672.
6. Taylor K.M., Snyder S.H. Brain histamine: rapid apparent turnover altered by restraint and cold stress. Science 1971, 172:1037-1039.
7. Mazurkiewicz-Kwilecki I.M. Single and repeated air blast stress and brain histamine. Pharmacol Biochem Behav 1980, 12:35-59.
8. Mazurkiewicz-Kwilecki I.M., Prell G.D. Brain histamine response to stress in 12month old rats. Life Sci 1986, 38:2339-2345.
9. Yoshitomi I., Itoh Y., Oishi R., Saeki K. Brain histamine turnover enhanced by footshock. Brain Res 1986, 362:195-198.
10. Oishi R., Nishibori M., Itoh Y., Saeki K. Diazepam-induced decrease in histamine turnover in mouse brain. Eur J Pharmacol 1986, 124:337-342.
11. Oishi R., Roh Y., Saeki K. Inhibition of histamine turnover by 8-OH-DPAT, buspirone and 5-hydroxytryptophan in the mouse and rat brain. Naunyn Schmiedebergs Arch Pharmacol 1992, 345:495-499.
12. Frisch C., Hasenohrl R.U., Krauth J., Hustaon J.P. Anxiolytic-like behavior after lesion of the tuberomammillary nucleus E2-region. Exp Brain Res 1998, 119:260-264.
13. Pellow S., Chopin P., File S., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
14. 1 receptors mediate l-histidine-induced anxiety in elevated plus-maze test in mice. Behav Pharmacol 2007, 18:213-217.
15. Hill S., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M., et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 1997, 49:253-278.
16. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000, 279:612-620.
17. 3) of histamine receptor. Nature 1983, 302:832-837.
18. 3-receptors. Neuroscience 1985, 15:553-562.
19. 3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. Eur J Pharmacol 1989, 164:1-11.
20. 3 receptor activation inhibits glutamate release from rat striatal synaptosomes. Neuropharmacology 2001, 41:928-934.
21. 3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience 1997, 80:241-249.
22. 3 receptors regulating acetylcholine release in rat entrohinal cortex. Br J Pharmacol 1995, 114:1518-1522.
23. 3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1988, 337:588-590.
24. Schlicker E., Fink K., Detzner M., Gothert M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J Neural Transm 1995, 93:1-10.
25. 3 receptors. Naunyn Schmiedebergs Arch Pharmacol 1989, 340:633-638.
26. 4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol 2009, 157:55-63.
27. Khodarahmi P., Sarahroodi S., Heydari Nasrabadi M., Sarafrazi F., Behboudi M. The effect of intraperitoneal histamine administration on the anxiety in rats. N Cell Mol Biotechnol J 2011, 1:43-48.
28. 3 receptor ligands in experimental models of anxiety and depression. Psychopharmacology 1999, 142:215-220.
29. Yokoyama F., Yamauchi M., Oyama M., Okuma K., Onozawa K., Nagayama T., et al. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology 2009, 205:177-187.
30. Ericson H., Blomqvist A., Kohler C. Origin of neuronal inputs to the region of the tuberomammillary nucleus of the rat brain. J Comp Neurol 1991, 311:45-64.
31. Sheehan T.P., Chambers R.A., Russell D.S. Regulation of affect by the lateral septum: implications for neuropsychiatry. Brain Res Rev 2004, 46:71-117.
32. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res 1996, 713:79-91.
33. Nagahara A.H., Handa R.J. Age-related changes in c-fos mRNA induction after open-field exposure in the rat brain. Neurobiol Aging 1997, 18:45-55.
34. Canteras N.S., Ribeiro-Barbosa E.R., Comoli E. Tracing from the dorsal premamillary nucleus prosencephalic systems involved in the organization of innate fear responses. Neurosci Biobehav Rev 2001, 25:661-668.
35. Dielenberg R.A., Hunt G.E., McGregor I.S. "When a rat smells a cat": the distribution of c-fos expression in rat brain following exposure to a predator odor. Neuroscience 2001, 104:1085-1097.
36. Cullinan W.E., Herman J.P., Battaglia D.F., Akil H., Watson S.J. Pattern and time course of immediate early gene expression in rat brain following acute stress. Neuroscience 1995, 64:447-505.
37. Menard J.L., Treit D. Lateral and medial septal lesions reduce anxiety in the plus-maze and probe-burying tests. Physiol Behav 1996, 60:845-853.
38. Pesold C., Treit D. The neuroanatomical specificity of the anxiolytic effects of intra-septal infusions of midazolam. Brain Res 1996, 710:161-168.
39. Degroot A., Kashluba S., Treit D. Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacol Biochem Behav 2001, 69:391-399.
40. Zarrindast M., Valizadegan F., Rostrami P., Rezayof A. Histaminergic system of the lateral septum in the modulation of anxiety-like behavior in rats. Eur J Pharmacol 2008, 583:108-114.
41. Wall P., Messier C. Methodological and conceptual issues in the use of the elevated plus-maze as a psychological measurement instrument of animal anxiety-like behavior. Neurosci Biobehav Rev 2001, 25:275-286.
42. Geen R., Tucci S., Edwards J., File S. Dietary restriction and nicotine can reduce anxiety in female rats. Neuropsychopharmacology 2003, 28:1257-1263.
43. Inoue K., Zorrilla E.P., Tabarin A., Valdez G.R., Iwasaki S., Kiriike N., et al. Reduction of anxiety after restricted feeding in the rat: implication for eating disorders. Biol Psychiatry 2004, 55:1075-1081.
44. Geen R., Tucci S., Thomas A., Edwards J., File S. Age-associated sex differences in response to food deprivation in two animal tests of anxiety. Neurosci Biobehav Rev 2003, 27:155-161.
45. 1-receptor mediates the motivational effects of novelty. Eur J Neurosci 2008, 27:1461-1474.
46. Sakata T., Fukagawa K., Ookuma K., Fujimoto K., Yoshimatsu H., Yamatodani A., et al. Hypothalamic neuronal histamine modulates ad libitum feeding by rats. Brain Res 1990, 537:303-306.
47. Morimoto T., Yamamoto Y., Yamatodan A. Brain histamine and feeding behavior. Behav Brain Res 2001, 124:145-150.
48. Merali Z., Levac C., Anisman H. Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice. Biol Psychiatry 2003, 54:552-564.
49. Hill S.J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990, 42:45-83.
50. van der Goot H., Timmerman H. Selective ligands as tools to study histamine receptors. Eur J Med Chem 2000, 35:5-20.
51. Fitzsimons C.P., Monczor F., Fernández N., Shayo C., Davio C. Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 2004, 279:34431-34439.
52. Daly M.J., Humphray J.M., Stables R. Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine. Br J Pharmacol 1981, 72:49-54.
53. 2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine. J Pharmacol Exp Ther 1983, 224:171-179.
54. 2 receptors. Proc Natl Acad Sci U S A 1996, 93:6802-6807.
55. Ligneau X., Lin J., Vanni-Mercier G., Jouvet M., Muir J.L., Ganellin C.R., et al. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 1998, 287:658-666.
56. 3-receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 1998, 358:623-627.
57. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, New York.
58. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995, 52:297-303.
59. Zarrindast M.R., Rostami P., Zarei M., Roohbakhsh A. Intracerebroventricular effects of histaminergic agents on morphine-induced anxiolysis in the elevated plus-maze in rats. Basic Clin Pharmacol Toxicol 2005, 97:276-281.
60. Meyers R.D. Handbook of drug and chemical stimulation of the brain: behavioral, pharmacological and physiological aspects 1974, Van Nostrand Reinhold, New York.
61. Crabbe J.C., Wahlsten D., Dudek B. Genetics of mouse behavior: interactions with laboratory environment. Science 1999, 284:1670-1672.
62. Trent N.T., Menard J.L. The ventral hippocampus and the lateral septum work in tandem to regulate rats' open-arm exploration in the elevated plus-maze. Physiol Behav 2010, 101:141-152.
63. Merrer J.L., Cagniard B., Cazala P. Modulation of anxiety by μ-opioid receptors of the lateral septum region in mice. Pharmacol Biochem Behav 2006, 83:465-479.
64. Zarrindast M., Monirsadat T., Rostami P., Fazli-Tabaei S. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 2006, 85:500-506.
65. Rostami P., Hajizadeh-Moghadam A., Zarrindast M.R. The effects of histaminergic agents in the ventral hippocampus of rats in the plus-maze test of anxiety-like behaviours. Physiol Behav 2006, 87:891-896.
66. Zarrindast M., Moghadam A.H., Rostami P., Roohbakhsh A. The effect of histaminergic agents in the central amygdala of rats in the elevated plus-maze test of anxiety. Behav Pharmacol 2005, 16:643-649.
67. 2 receptors of the periaqueductal gray and inferior colliculus induces fear-like behaviors. Pharmacol Biochem Behav 2003, 75:25-33.
68. Risold P.Y., Swanson L.W. Connections of the rat lateral septal complex. Brain Res Rev 1997, 24:115-195.
69. Menard J.L., Treit D. Intra-septal infusions of excitatory amino acid receptor antagonists have differential effects in two animal models of anxiety. Behav Pharmacol 2000, 11:99-108.
70. Menard J.L., Treit D. The anxiolytic effects of intra-hippocampal midazolam are antagonized by intra-septal l-glutamate. Brain Res 2001, 888:163-166.
71. Degroot A., Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res 2004, 1001:60-71.
72. Privou C., Knoche A., Hasenöhrl R.U., Huston J.P. The H1 and H2 histamine blockers chlorpheniramine and ranitidine applied to the nucleus basalis magnocellularis region modulate anxiety and reinforcement related processes. Neuropharmacology 1998, 37:1019-1032.
73. 1 receptor antagonist-induced spatial memory deficits in rats. Eur J Pharmacol 2001, 423:167-170.
74. Liebsch G., Wotjak C.T., Landgraf R., Engelmann M. Septal vasopressin modulates anxiety-related behaviors in rats. Neurosci Lett 1996, 217:101-104.
75. 2 receptors facilitates catecholaminergic metabolism and aggravates ischemic brain damage in the rat telencephalon. Brain Res 2003, 974:117-126.
76. 1A receptors in mediating the anxiogenic effects of nicotine following lateral septal administration. Eur J Neurosci 2000, 12:3797-3802.
77. Risold P.Y., Swanson L.W. Chemoarchitecture of the rat lateral septal nucleus. Brain Res Rev 1997, 24:91-113.
78. Chee S.S., Menard J.L. Lesions of the dorsal lateral septum do not affect neophagia in the novelty induced suppression of feeding paradigm but reduce defensive behaviours in the elevated plus maze and shock probe burying tests. Behav Brain Res 2011, 220:362-366.